in adults with type 2 diabetes and chronic kidney disease. Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection ...
By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
About 40% of people with type 2 diabetes have chronic kidney disease, according to Novo Nordisk. Type 2 diabetes impacts approximately 37 million adults in the US, the company noted in a press ...
The FDA approves Ozempic for the treatment of chronic kidney disease in patients who also have type 2 diabetes. Ozempic and other diabetes drugs known as GLP-1s have become popular and also well ...
in adults with type 2 diabetes and chronic kidney disease. Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection in the ...